Universitair Ziekenhuis Brussel
uzbrussel.beLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
385
Active
92
Phase 3
14
Total enrollment
61,682
Pipeline matrix
Showing 15 of 15 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| 68GaNOTA-Anti-MMR-VHH2 | — | — | — | — | — | 3 | |
| Ipilimumab | — | — | — | — | — | 2 | |
| Nivolumab | — | — | — | — | — | 2 | |
| Pembrolizumab | — | — | — | — | — | 1 | |
| Autologous CD1c(BDCA-1)+ /CD141(BDCA-3)+ myDC | — | — | — | — | — | 1 | |
| Olaparib Oral | — | — | — | — | — | 1 | |
| intratumoral injection of autologous CD1c (BDCA-1)+ myDC | — | — | — | — | — | 1 | |
| Intratumoral injection of ipilimumab and AS01b | — | — | — | — | — | 1 | |
| IV nivolumab | — | — | — | — | — | 1 | |
| Neo-adjuvant nivolumab and ipililumab IV + adjuvant nivolumab and ipililumab IV | — | — | — | — | — | 1 | |
| Adjuvant nivolumab IV + nivolumab and ipililumab intracavitary | — | — | — | — | — | 1 | |
| Paclitaxel Chemotherapy | — | — | — | — | — | 1 | |
| genomic mutations study | — | — | — | — | — | 1 | |
| Comprehensive Medical Management | — | — | — | — | — | 1 | |
| Ovitrelle injection for ovulation induction | — | — | — | — | — | 1 |
Next readouts
- 2024-12-31
- 2025-05-06
- 2025-06-01
- 2025-12-24
- 2026-06-30
- 2026-11-17
- 2026-12-31
- 2027-04-01
- 2028-02
- 2029-10-31
Top conditions
- Infertility30
- Failed Back Surgery Syndrome8
- Pregnancy7
- Breast Cancer6
- Brugada Syndrome6
- Pain6
- Infertility, Female6
- Irritable Bowel Syndrome5
Frequently asked questions about Universitair Ziekenhuis Brussel
- How many clinical trials does Universitair Ziekenhuis Brussel have on ClinicalTrials.gov?
- Universitair Ziekenhuis Brussel is listed as the lead sponsor on 385 clinical trials in ClinicalTrials.gov, 92 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Universitair Ziekenhuis Brussel's trials are in Phase 3?
- 14 of Universitair Ziekenhuis Brussel's trials are in Phase 3, spread across 15 active drug programs.
- What therapeutic areas does Universitair Ziekenhuis Brussel focus on?
- Universitair Ziekenhuis Brussel's most-studied conditions on ClinicalTrials.gov are Infertility, Failed Back Surgery Syndrome, Pregnancy, Breast Cancer, Brugada Syndrome.
- When are Universitair Ziekenhuis Brussel's next clinical trial readouts?
- Universitair Ziekenhuis Brussel has 10 upcoming primary-completion readouts tracked here; the soonest is “Efficacy of Olaparib in Advanced Cancers Occurring in Patients With Germline Mutations or Somatic Tumor Mutations in Homologous Recombination Genes”, expected around 2024-12-31.